Oral misoprostol may leads to lower vaginal birth within 24 hours compared with vaginal misoprostol (low certainty).
Oral misoprostol showed no clear difference in vaginal birth within 24 hours compared with vaginal dinoprostone (low certainty).
The review found no eligible studies for this question.
Oral misoprostol showed no clear difference in caesarean section compared with vaginal misoprostol (low certainty).
Oral misoprostol may leads to lower uterine hyperstimulation with fetal heart rate changes compared with vaginal misoprostol (low certainty).
Oral misoprostol may leads to higher oxytocin augmentation compared with vaginal misoprostol (low certainty).
Oral misoprostol may leads to lower uterine hyperstimulation without fetal heart rate changes compared with vaginal misoprostol (low certainty).
Oral misoprostol showed no clear difference in apgar score less than seven at five minutes compared with vaginal misoprostol (low certainty).
Oral misoprostol showed no clear difference in admission to neonatal intensive care unit compared with vaginal misoprostol (moderate certainty).
Oral misoprostol showed no clear difference in vaginal birth within 24 hours compared with intravenous oxytocin (low certainty).
Oral misoprostol showed no clear difference in vaginal birth within 24 hours compared with mechanical methods (low certainty).
Oral misoprostol probably leads to higher failure to achieve complete abortion compared with vaginal misoprostol (moderate certainty).
Oral misoprostol may leads to higher nausea compared with vaginal misoprostol (low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
It is very uncertain whether oral misoprostol one‐ to two‐hourly changes vaginal birth within 24 hours compared with oral misoprostol four‐ to six‐hourly (very low certainty).
Oral misoprostol 20 µg hourly titrated showed no clear difference in vaginal birth within 24 hours compared with oral misoprostol 25 µg two‐hourly static (low certainty).
Oral misoprostol may leads to lower uterine hyperstimulation with fetal heart rate changes compared with vaginal dinoprostone (low certainty).
It is very uncertain whether oral misoprostol changes oxytocin augmentation compared with vaginal dinoprostone (very low certainty).
Oral misoprostol probably leads to lower uterine hyperstimulation without fetal heart rate changes compared with vaginal dinoprostone (moderate certainty).